Steve Eisman Expresses Caution Over SpaceX's IPO Amid Rising Capital Expenditures

iconKuCoinFlash
Share
Share IconShare IconShare IconShare IconShare IconShare IconCopy
AI summary iconSummary

expand icon
Investor sentiment toward SpaceX’s upcoming IPO has turned cautious after Steve Eisman highlighted rising capital demands. In a recent CNBC interview, Eisman noted that capital expenditures surged to 215% of revenue in the latest quarter, up from 42% in 2023. The shift has sparked debate among investors, with some turning their attention to altcoins as alternative investment opportunities. Market observers are closely monitoring how investor sentiment evolves ahead of the listing.

Odaily Planet Daily reports that SpaceX is preparing for a record-breaking initial public offering (IPO), but prominent investor Steve Eisman has expressed concerns about its artificial intelligence business. Eisman, the real-life inspiration for the trader who bet against the housing market in the movie "The Big Short," told CNBC on Monday that while he does not plan to short SpaceX stock at the time of the IPO, the company’s prospectus has raised some red flags: SpaceX’s capital expenditures have risen significantly—capital spending accounted for only 42% of revenue in fiscal year 2023, but has now reached 215% of revenue in the most recent quarter, indicating the company has become highly capital-intensive. (Business Insider)

Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.